샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793774

세계의 재생요법 시장

Regenerative Therapies
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 287 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

재생요법 세계 시장은 2030년까지 174억 달러에 달할 전망

2024년에 112억 달러로 추정되는 재생요법 세계 시장은 2024년부터 2030년까지 CAGR 7.7%로 성장하여 2030년에는 174억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 세포 치료는 CAGR 9.2%를 기록하며 분석 기간 종료시에는 78억 달러에 달할 것으로 예측됩니다. 줄기세포 치료 분야의 성장률은 분석 기간 동안 CAGR 5.7%로 추정됩니다.

미국 시장은 30억 달러로 추정, 중국은 CAGR 12.3%로 성장 예측

미국의 재생요법 시장은 2024년에 30억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 38억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 12.3%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.8%와 7.5%로 예측됩니다. 유럽에서는 독일이 CAGR 5.1%로 성장할 것으로 예측됩니다.

세계의 재생요법 시장 - 주요 동향과 촉진요인 정리

재생요법이 의료의 미래를 바꾸는 이유는 무엇인가?

재생요법은 질병이나 손상된 세포, 조직, 장기를 복구, 대체, 재생하는 것을 목표로 하는 첨단 의료의 혁신적 분야입니다. 이러한 치료법은 줄기세포, 조직공학, 유전자 편집, 생체공학 물질을 활용하여 신체의 자연 치유 과정을 자극합니다. 기존 치료는 증상을 억제하거나 질병의 진행을 막는 경우가 많았지만, 재생요법은 생물학적 기능을 완전히 회복시키려는 것입니다. 그 적용 범위는 정형외과적 손상, 심혈관질환, 신경 퇴행성 질환, 자가 면역 질환, 심지어 장기 재생에 이르기까지 다양합니다.

줄기세포를 이용한 치료법, 특히 간엽줄기세포(MSCs)는 연골 재생, 상처 치유, 허혈성 질환에 있어 최전선에 서 있습니다. 줄기세포는 면역조절 작용을 나타내며 여러 조직형으로 분화할 수 있어 그 유용성이 높아지고 있습니다. 한편, 인공만능줄기세포(iPSC)는 면역거부반응의 위험을 줄인 자가치료를 추진하고 있습니다. 또한, 바이오스커폴딩과 3D 바이오프린팅의 발전은 특히 정형외과 및 재건 의료 분야에서 구조적으로 실행 가능한 조직을 구축할 수 있게 해줍니다. 이러한 기술 혁신은 만성질환을 세포 및 분자 수준에서 다루게 되는 패러다임의 전환을 가져오고 있습니다.

새로운 기술과 플랫폼은 어떻게 임상적 효과를 높이고 있는가?

이 분야는 유전자 편집 세포 치료, 기성품 동종 이식 플랫폼, 정밀의료의 통합으로 급속한 기술 혁신이 진행되고 있습니다. CRISPR/Cas9 및 염기교정 기술은 효과와 내구성을 높이기 위해 재생 프로토콜에 통합되고 있습니다. 예를 들어, 조혈모세포 편집은 겸상 적혈구빈혈이나 베타 지중해빈혈과 같은 혈액질환의 잠재적 치료법으로 떠오르고 있습니다. 또한, 엑소좀을 포함한 세포외소포체 연구의 발전은 생세포와 관련된 위험 없이 재생 가능성이 있다는 점에서 지지를 받고 있습니다.

바이오 제조는 자동화, 폐쇄형 루프 시스템, 일관된 제품 품질을 위한 확장 가능한 플랫폼으로 진화하고 있습니다. 모듈식 클린룸, 로봇식 세포배양 시스템, GMP에 준하는 냉동보관 기술로 비용을 절감하고 산업적 확장성을 확보할 수 있게 되었습니다. AI와 머신러닝 알고리즘은 환자별 오믹스 데이터를 분석하고, 재생요법에 대한 반응을 예측하고, 임상시험 설계를 간소화하기 위해 도입되고 있습니다. 이러한 기술들은 특히 다발성 경화증이나 1형 당뇨병과 같은 이질성이 높은 질환에서 신제품의 시장 출시 시간을 단축하고 치료 정확도를 높이고 있습니다.

시장 수요를 주도하는 치료 영역과 전달 모델은?

정형외과 및 근골격계 응용 분야, 특히 연골 복구, 힘줄 재생, 척수 손상에 대한 응용 분야가 현재 시장을 지배하고 있습니다. 혈소판풍부혈장(PRP) 및 줄기세포 주사는 최소침습적이고 회복을 촉진한다는 증거로 인해 스포츠 의학 및 신체 재활에 널리 사용되고 있습니다. 심혈관계 재생요법 심부전이나 허혈성 사지 상태에 대한 심근세포 대체, 혈관 재생 등 심혈관계도 활기를 띠고 있습니다. 신경질환, 특히 뇌졸중, 파킨슨병, 알츠하이머병은 강력한 연구 파이프라인을 가진 신흥 분야입니다.

의료 제공 모델은 입원 중인 병원 환경에서 외래 진료소, 외래 재생요법센터, 전문 정형외과 클리닉으로 확대되고 있습니다. 이러한 분산화는 POC(Point-of-Care) 제조와 소형화된 바이오프로세싱 툴의 발전으로 뒷받침되고 있습니다. 동종 세포은행은 보다 빠른 전달 주기를 가능하게 하고 자가 조직 채취에 대한 의존도를 낮추고 있습니다. 동반진단, 실시간 영상 진단, 바이오마커를 통한 투약 전략은 치료 성과와 모니터링을 더욱 최적화하고 있습니다. 진단학, 재생 생체재료, 디지털 헬스 툴의 융합은 보다 포괄적이고 적응력이 높은 전달 생태계를 가능하게 하고 있습니다.

재생요법 시장의 성장을 촉진하는 요인은 무엇인가?

재생요법 시장의 성장은 미충족된 임상적 수요, 고령화 인구구조, 우호적인 규제 프레임워크, 공공 및 민간 투자 증가에 기인합니다. 만성질환, 노화에 따른 퇴행성 질환, 외상 등은 기존의 치료법으로는 충분히 대처할 수 없어 치료적 또는 기능 회복적 개입에 대한 수요가 지속적으로 증가하고 있습니다. 북미, 유럽, 아시아태평양에서는 인구 고령화가 진행되면서 골관절염, 심혈관질환, 신경 퇴행성 질환에 대한 재생요법의 필요성이 증가하고 있습니다.

미국 FDA의 RMAT(Regenerative Medicine Advanced Therapy) 지정과 유럽의 ATMP(Advanced Therapy Medicines) 규제 경로와 같은 정책적 프레임워크는 승인 절차를 가속화하고 혁신에 대한 인센티브를 제공하고 있습니다. 또한, 수십억 달러의 벤처 자금과 민관 파트너십이 임상시험, 연구 인프라, 바이오 제조의 스케일업에 박차를 가하고 있습니다. NIH, CIRM(캘리포니아 재생의학연구소), 일본의 AMED와 같은 기관들이 전 세계 연구개발의 기세를 올리고 있습니다. 유효성과 가격 문제가 해결되는 한, 재생요법은 틈새 혁신에서 부담스러운 치료 영역 전반의 주류 치료로 전환할 준비가 되어 있습니다.

부문

치료 유형(세포 치료, 줄기세포 치료, 조직공학 치료, 유전자 치료), 용도(상처 치료, 근골격계, 종양학, 치과, 듀셴형 근이영양증 , 간질환, 염증성·자가면역질환, 기타 용도)

조사 대상 기업 사례

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Biogen Inc.
  • Bristol Myers Squibb Company
  • Corestem, Inc.
  • Fate Therapeutics
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Integra LifeSciences Corporation
  • Medtronic plc
  • Merck KGaA
  • Mesoblast Ltd.
  • MiMedx Group, Inc.
  • Novartis AG
  • Organogenesis Holdings Inc.
  • Pfizer Inc.
  • Sarepta Therapeutics Inc.
  • Smith & Nephew plc
  • Takeda Pharmaceutical Company Limited
  • Vericel Corporation

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.27

Global Regenerative Therapies Market to Reach US$17.4 Billion by 2030

The global market for Regenerative Therapies estimated at US$11.2 Billion in the year 2024, is expected to reach US$17.4 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2024-2030. Cell Therapy, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$7.8 Billion by the end of the analysis period. Growth in the Stem Cell Therapy segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 12.3% CAGR

The Regenerative Therapies market in the U.S. is estimated at US$3.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 12.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Regenerative Therapies Market - Key Trends & Drivers Summarized

Why Are Regenerative Therapies Reshaping the Future of Medicine?

Regenerative therapies represent a transformative segment within advanced medicine, aiming to repair, replace, or regenerate diseased or damaged cells, tissues, or organs. These therapies leverage stem cells, tissue engineering, gene editing, and bioengineered materials to stimulate the body’s natural healing processes. Unlike conventional treatments that often manage symptoms or halt disease progression, regenerative therapies attempt to restore full biological function. Their applications extend across orthopedic injuries, cardiovascular diseases, neurodegenerative disorders, autoimmune diseases, and even organ regeneration.

Stem cell-based therapies, particularly mesenchymal stem cells (MSCs), remain at the forefront, especially in cartilage regeneration, wound healing, and ischemic diseases. They exhibit immunomodulatory effects and can differentiate into multiple tissue types, enhancing their utility. Meanwhile, induced pluripotent stem cells (iPSCs) are driving forward autologous treatments with reduced risk of immune rejection. Additionally, advancements in bio-scaffolding and 3D bioprinting are enabling structurally viable tissue constructs, especially in orthopedic and reconstructive medicine. These innovations are ushering in a paradigm shift where chronic ailments are increasingly addressed at a cellular and molecular level.

How Are Emerging Technologies and Platforms Enhancing Clinical Efficacy?

The field is undergoing rapid innovation through gene-edited cell therapies, off-the-shelf allogeneic platforms, and precision medicine integration. CRISPR/Cas9 and base editing technologies are being integrated into regenerative protocols to enhance efficacy and durability. For instance, editing hematopoietic stem cells is emerging as a potential cure for blood disorders like sickle cell anemia and beta-thalassemia. Furthermore, advancements in extracellular vesicle research, including exosomes, are gaining traction for their regenerative potential without the risks associated with live cells.

Biomanufacturing is evolving through automation, closed-loop systems, and scalable platforms for consistent product quality. Modular cleanrooms, robotic cell culture systems, and GMP-compliant cryopreservation techniques are reducing costs and enabling industrial scalability. AI and machine learning algorithms are being deployed to analyze patient-specific omics data, predict response to regenerative treatments, and streamline clinical trial design. These technologies are reducing time-to-market for new products and increasing therapeutic precision, particularly in diseases with high heterogeneity such as multiple sclerosis or Type 1 diabetes.

Which Therapeutic Areas and Delivery Models Are Driving Market Demand?

Orthopedic and musculoskeletal applications dominate current market usage, particularly in cartilage repair, tendon regeneration, and spinal cord injury. Platelet-rich plasma (PRP) and stem cell injections are widely used in sports medicine and physical rehabilitation due to their minimally invasive nature and evidence of enhanced recovery. Cardiovascular regenerative therapies are also gaining momentum, including myocardial cell replacement and vascular regeneration for heart failure and ischemic limb conditions. Neurological disorders-particularly stroke, Parkinson’s disease, and ALS-are emerging areas with a robust research pipeline.

Delivery models are expanding beyond inpatient hospital settings to include ambulatory clinics, outpatient regenerative therapy centers, and specialized orthobiologic practices. This decentralization is supported by advances in point-of-care manufacturing and miniaturized bioprocessing tools. Allogeneic cell banks are enabling faster delivery cycles and reduced dependency on autologous tissue harvesting. Companion diagnostics, real-time imaging, and biomarker-guided dosing strategies are further optimizing therapeutic outcomes and monitoring. The convergence of diagnostics, regenerative biomaterials, and digital health tools is enabling a more holistic and adaptive delivery ecosystem.

What Factors Are Driving the Growth of the Regenerative Therapies Market?

The growth in the regenerative therapies market is driven by unmet clinical needs, aging demographics, supportive regulatory frameworks, and increased investment from public and private sectors. Chronic diseases, age-related degeneration, and traumatic injuries remain inadequately addressed by conventional therapies, creating a persistent demand for curative or function-restoring interventions. Aging populations in North America, Europe, and parts of Asia-Pacific are also contributing to the need for regenerative solutions in osteoarthritis, cardiovascular disease, and neurodegeneration.

Policy frameworks such as the U.S. FDA’s RMAT (Regenerative Medicine Advanced Therapy) designation and Europe’s ATMP (Advanced Therapy Medicinal Products) regulatory pathway are expediting approval processes and incentivizing innovation. Additionally, billions of dollars in venture funding and public-private partnerships are fueling clinical trials, research infrastructure, and biomanufacturing scale-up. Institutions like the NIH, CIRM (California Institute for Regenerative Medicine), and Japan’s AMED are catalyzing global R&D momentum. As long as efficacy and affordability challenges are addressed, regenerative therapies are poised to move from niche innovation to mainstream treatment across high-burden therapeutic areas.

SCOPE OF STUDY:

The report analyzes the Regenerative Therapies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Therapy Type (Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy, Gene Therapy); Application (Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application, Duchenne Muscular Dystrophy Application, Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Biogen Inc.
  • Bristol Myers Squibb Company
  • Corestem, Inc.
  • Fate Therapeutics
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Integra LifeSciences Corporation
  • Medtronic plc
  • Merck KGaA
  • Mesoblast Ltd.
  • MiMedx Group, Inc.
  • Novartis AG
  • Organogenesis Holdings Inc.
  • Pfizer Inc.
  • Sarepta Therapeutics Inc.
  • Smith & Nephew plc
  • Takeda Pharmaceutical Company Limited
  • Vericel Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Regenerative Therapies - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Breakthroughs in Stem Cell Research Propel Innovation in Regenerative Therapies
    • Advancements in 3D Bioprinting Technologies Expand Clinical Possibilities
    • Surge in Chronic Disease Prevalence Drives Adoption of Tissue Regeneration Solutions
    • Global Investments in Cell and Gene Therapy Manufacturing Facilities Accelerate Development
    • Rising Incidence of Degenerative Disorders Strengthens Market Opportunity
    • Patient-Centric Personalized Therapies Fuel Custom Regenerative Product Demand
    • Regulatory Pathway Clarity Across Major Markets Encourages Clinical Advancements
    • Cross-Industry Collaborations Propel Platform Technologies in Regenerative Medicine
    • Expansion of Clinical Trials for Musculoskeletal Disorders Spurs Therapy Validation
    • Government Funding for Translational Medicine Bolsters Therapy Commercialization
    • Emergence of Allogeneic Cell Platforms Reduces Production and Scalability Constraints
    • Integration of Artificial Intelligence Enhances Regenerative Drug Discovery Pipelines
    • Growing Demand for Anti-Aging Treatments Opens New Consumer-Facing Opportunities
    • Availability of Cryopreservation Infrastructure Enables Widespread Cell Banking
    • Academic and Industrial Partnerships Foster Advanced R&D Capabilities
    • Shift Toward Minimally Invasive Therapeutic Modalities Drives Delivery Innovation
    • Patient Awareness Campaigns Strengthen Demand for Regenerative Solutions
    • Increased Patent Activity Reflects Intensifying Innovation Race in Biologics
    • Expansion of Point-of-Care Manufacturing Models Optimizes Treatment Delivery
    • Ethical Acceptance and Regulatory Backing Improve Access in Emerging Markets
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Regenerative Therapies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Regenerative Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Tissue engineering Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Tissue engineering Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Tissue engineering Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hepatological Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hepatological Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Hepatological Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Inflammatory & Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Inflammatory & Autoimmune Diseases Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Inflammatory & Autoimmune Diseases Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Wound Care Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Wound Care Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: World 16-Year Perspective for Wound Care Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Musculoskeletal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Musculoskeletal Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: World 16-Year Perspective for Musculoskeletal Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Oncology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: World 16-Year Perspective for Oncology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Dental Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Dental Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: World 16-Year Perspective for Dental Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Duchenne Muscular Dystrophy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Duchenne Muscular Dystrophy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: World 16-Year Perspective for Duchenne Muscular Dystrophy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • CHINA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: China 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Regenerative Therapies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Germany 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Italy 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 89: Italy Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Italy Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Italy 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: UK 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 95: UK Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: UK Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: UK 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 98: Spain Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Spain Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Spain 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 101: Spain Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Spain Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Spain 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 104: Russia Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Russia Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Russia 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 107: Russia Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Russia Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Russia 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: Rest of Europe 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Rest of Europe Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: Rest of Europe 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific Historic Review for Regenerative Therapies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: Asia-Pacific 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Asia-Pacific Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: Asia-Pacific 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Asia-Pacific Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Asia-Pacific 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 125: Australia Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Australia Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Australia 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 128: Australia Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Australia Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Australia 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • INDIA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 131: India Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: India Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: India 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 134: India Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: India Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: India 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 137: South Korea Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: South Korea Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: South Korea 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 140: South Korea Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: South Korea Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: South Korea 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 143: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Asia-Pacific Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Rest of Asia-Pacific 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Asia-Pacific Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Asia-Pacific 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 149: Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 150: Latin America Historic Review for Regenerative Therapies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Latin America 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 152: Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Latin America Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Latin America 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 155: Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Latin America Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Latin America 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 158: Argentina Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Argentina Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Argentina 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 161: Argentina Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Argentina Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Argentina 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 164: Brazil Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Brazil Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Brazil 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 167: Brazil Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Brazil Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Brazil 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 170: Mexico Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Mexico Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Mexico 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 173: Mexico Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Mexico Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Mexico 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 176: Rest of Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Latin America Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Latin America 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Latin America Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Latin America 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 182: Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 183: Middle East Historic Review for Regenerative Therapies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Middle East 16-Year Perspective for Regenerative Therapies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 185: Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Middle East Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Middle East 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 188: Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Middle East Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: Middle East 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 191: Iran Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Iran Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: Iran 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 194: Iran Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Iran Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Iran 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 197: Israel Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Israel Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Israel 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 200: Israel Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Israel Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Israel 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 203: Saudi Arabia Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Saudi Arabia Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Saudi Arabia 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Saudi Arabia Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 208: Saudi Arabia 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 209: UAE Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: UAE Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 211: UAE 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 212: UAE Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: UAE Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 214: UAE 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 215: Rest of Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Rest of Middle East Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 217: Rest of Middle East 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Rest of Middle East Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 220: Rest of Middle East 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Regenerative Therapies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 221: Africa Recent Past, Current & Future Analysis for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Africa Historic Review for Regenerative Therapies by Therapy Type - Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 223: Africa 16-Year Perspective for Regenerative Therapies by Therapy Type - Percentage Breakdown of Value Sales for Cell Therapy, Stem Cell Therapy, Tissue engineering Therapy and Gene Therapy for the Years 2014, 2025 & 2030
    • TABLE 224: Africa Recent Past, Current & Future Analysis for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Africa Historic Review for Regenerative Therapies by Application - Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 226: Africa 16-Year Perspective for Regenerative Therapies by Application - Percentage Breakdown of Value Sales for Hepatological Diseases Application, Inflammatory & Autoimmune Diseases Application, Other Applications, Wound Care Application, Musculoskeletal Application, Oncology Application, Dental Application and Duchenne Muscular Dystrophy Application for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제